Subsection
Medication Safety sits under Chronic Condition Management . Interactions, deprescribing, adherence, and adverse-event reporting explained plainly.
6 stories
Late August 2026 brought a wave of FDA recalls affecting Clear Eyes eye drops, alfalfa sprouts linked to E. coli and salmonella, a dabigatran impurity pull, and a TikTok-famous collagen. Here is what to check, what to do, and how to spot a recall before the next dose.
Walmart agreed to pay $50 million to settle Justice Department claims that its pharmacies filled suspicious opioid prescriptions for years. The case is the first major federal action against a retail pharmacy chain for its role in the opioid epidemic, and it changes what patients should expect at the counter.
Generic drug shortages are rising, leaving patients scrambling for staples like stimulants, antibiotics, and sterile injectables. Here is why it happens and what to do when your drug is gone.
The FDA approved suzetrigine (Journavx) in January 2025 as the first new-class non-opioid pain pill in decades. Here is how it works, who it helps, and its limits.
FDA drug and supplement recalls surged in 2026 — from a TikTok collagen recall to a dabigatran impurity pull. Here is the step-by-step way to check whether your bottle is affected before you take it.
New studies show semaglutide can accelerate muscle loss in older adults with type 2 diabetes, especially at higher doses. Here is what clinicians recommend for protection.
More from Chronic Condition Management .
